Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Amylx Pharmaceuticals Inc (AMLX) vs Keysight Technologies Inc (KEYS) Price & Performance

Amylx Pharmaceuticals IncTrade
Keysight Technologies IncTrade

Price performance (Past 24H)

Key statistics

Amylx Pharmaceuticals Inc vs Keysight Technologies Inc — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while Keysight Technologies Inc trades at $351 (market cap $58.74B). The key difference: Keysight Technologies Inc is far larger — about 22.3× Amylx Pharmaceuticals Inc's market cap. Which is the better fit depends on your goals.

AMLXKEYS
Market Cap
$2.64B$58.74B
Sector
HealthTechnology
52-Week High
$24.19$373.34
52-Week Low
$7.82$158.51
Enterprise Value
$2.39B$59.08B

Returns comparison

Trailing returns across standard periods

About Amylx Pharmaceuticals Inc

Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.

Read more on AMLX

About Keysight Technologies Inc

Keysight Technologies is a leader in the field of testing and measurement, helping electronics OEMs and suppliers alike bring products to market to fit industry standards and specifications. Keysight specializes in the communications market, but also supplies into the government, automotive, industrial, and semiconductor manufacturing markets. Keysight's solutions include testing tools, analytical software, and services. The firm's stated objective is to reduce time to market and improve efficiency at its more than 30,000 customers.

Read more on KEYS